Nordic Capital and Apax France divest their respective stakes in Unilabs

Private equity funds Nordic Capital Fund VI and Apax France VII have agreed to divest their respective stakes in Unilabs to Apax IX, advised by Apax Partners LLP. The transaction marks the successful completion of the joint ownership between funds advised by Apax Partners LLP, Nordic Capital and Apax Partners France (jointly with Altamir), which saw Unilabs taken private from the Swiss stock exchange in November 2007 and merged with the diagnostic division of pan-European healthcare provider Capio in 2008. Financial terms of the transaction are not being disclosed.

With over 5,300 employees, 112 laboratories and 43 medical imaging units across 10 European countries and emerging positions in the Middle East and Latin America, Unilabs has grown to become one of Europe’s leading medical diagnostics businesses.

Nordic Capital was advised by Mannheimer Swartling in the transaction.

Cookies

This website uses cookies to perform certain functions and help you navigate the site efficiently. A cookie is a text file with a small amount of information that is stored on your device. We share some of the information we obtain through these cookies with third parties. We only use cookies that are necessary for the site to function correctly and they therefore cannot be turned off. For further information, see Information on the use of cookies.